Close Menu

This story has been updated with additional details from UnitedHealthcare's coverage policy.

NEW YORK – UnitedHealthcare has issued a positive coverage decision for Myriad Genetics' GeneSight Psychotropic pharmacogenetic test, Myriad disclosed in a filing with the US Securities and Exchange Commission today.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Atlantic reports another SARS-CoV-2 testing problem may be lurking: backlogs.

Researchers have sequenced the genome of "the Methuselah of freshwater fish."

The US Biomedical Advanced Research and Development Authority is supporting efforts to develop vaccines against SARS-CoV-2.

In Genome Biology this week: difference in methylation in neurons from Parkinson's disease patients, differential expression analysis by barcoded sequencing approach, and more.